期刊文献+

缺血性股骨头坏死患者血清同型半胱氨酸与超敏C反应蛋白的临床研究 被引量:7

Study on serum homocysteine and high-sensitive C-reactive protein in patients with avascular necrosis in femoral head
下载PDF
导出
摘要 目的:检测缺血性股骨头坏死患者血清同型半胱氨酸(HCY)、超敏C反应蛋白(hs-CRP)、白细胞介素-1β(IL-1β)、肿瘤坏死因子-α(TNF-α)浓度值,探讨HCY、hs-CRP在缺血性股骨头坏死发病机制中作用。方法:实验分为4组,非股骨头坏死正常组(N组)、股骨头坏死Ⅰ期组(N1组)、股骨头坏死Ⅱ期组(N2组)、股骨头坏死Ⅲ期组(N3组)。双抗体夹心ELISA法测定hs-CRP、IL-1β、TNF-α,采用荧光标记免疫检测法检测血清HCY水平,生物化学法测定血脂。结果:N1、N2、N3组和N组比较,HCY、hs-CRP、IL-1β、TNF-α浓度明显升高(P<0.01);N3组和N1组比较,HCY、hs-CRP、IL-1β、TNF-α浓度明显增高(P<0.01)。结论:HCY、hs-CRP参与缺血性股骨头坏死的发病机制。HCY参与缺血性股骨头坏死发生发展的炎性反应过程,炎症反应可能是缺血性股骨头坏死的促发因素。 Objective To detect the serum levels of homocysteine (HCY), high-sensitive C-reactive protein (hs- CRP), interleukin-1β (IL-1β), and tumor necrosis factor-α (TNF-α) in patients with avascular necrosis in femoral head, and to explore the role of HCY and hs-CRP in the pathogenesis of it. Methods Patients with avaseular necrosis in femoral head were divided into 4 groups, normal group (group N), stage-one of necrosis in femoral head group (group N1 ), stage- two of necrosis in femoral head group (group N2), and stage-three of necrosis in femoral head group (group N3). Serum levels of hs-CRP, interleukin-1β (IL-1β), and TNF-α were measured by enzyme linked immunosorbent assay, HCY was measured by immunofluorescenee, and blood lipid was detected by biochemical method. Results The serum levels of HCY, hs-CRP, IL-1β, TNF-α were significantly higher in group N1, N2, and N3 than in group N (P 〈 0.01), and were significantly higher in group N3 than in group N1 (P 〈 0.01). Conclusions HCY and hs-CRP may participate in the pathogenesis of avascular necrosis in femoral head. HCY may play an important role in the process of inflammatory reaction, which may be a precipitating factor in avascular necrosis in femoral head.
作者 万革 袁新
出处 《实用医学杂志》 CAS 北大核心 2009年第9期1415-1417,共3页 The Journal of Practical Medicine
基金 重庆市自然科学基金资助项目(编号:cqsf07k012)
关键词 股骨头坏死 同型半胱氨酸 超敏C反应蛋白 Femur head necrosis Homocysteine High-sensitive C-reactive protein
  • 相关文献

参考文献10

  • 1Folin M, Baiguera S, Gallucci M, et al. A cross-sectional study of homocysteine-, NO-levels, and CT-findings in Alzheimer dementia, vascular dementia and controls [J]. Biogemntology, 2005,6 (4): 255-260.
  • 2Kawamura T, Umemura T, Kanai A, et al. Soluble adhesion molecules and C-reactive protein in the progression of silent cerebral infarction in patients with type 2 diabetes mellitus [J]. Metabolism, 2006,55(4) :461-466.
  • 3Liacini A, Sylvester J, Li W Q, et al. Induction of matrix metalloproteinase-13 gene expression by TNF-alpha is mediated by MAP kinases, AP-1, and NF-kappaB transcription factors in articular chondrocytes [J ]. Exp Cell Res, 2003,288 ( 1 ) :208-217.
  • 4Sylvester J, Liacini A, Li W Q, et al. Tripterygium wilfordii Hook F extract suppresses proinflammatory cytokine-induced expression of matrix metalloproteinase genes in articular chondrocytes by inhibiting activating protein-1 and nuclear factor-kappaB activities [J]. Mol Pharmacol. 2001,59 ( 5 ) : 1196-1205.
  • 5Ravaglia G, Forti P, Maioli F, et al. Blood inflammatory markers and risk of dementia: The Conselice Study of Brain Aging [J]. Neurobiol Aging, 2007,28(12) : 1810-1820.
  • 6Roman G C. Vascular dementia prevention: a risk factor analysis [J]. Cerebrovasc Dis, 2005,20 (Suppl 2):91-100.
  • 7Ban Y, Watanabe T, Miyazaki A, et al. Impact of increased plasma serotonin levels and carotid atherosclerosis on vascular dementia [J ]. Atherosclerosis, 2007,195 ( 1 ) : 153-159.
  • 8Mielke M M, Zandi P P. Hematologic risk factors of vascular disease and their relation to dementia [J]. Dement Geriatr Cogn Disord, 2006,21 ( 5-6 ) : 335-352.
  • 9Elishkewich K, Kaspi D, Shapira I, et al. Idiopathic osteonecrosis in an adult with familial protein S deficiency and hyperhomocysteinemia [J]. Blood Coagul Fibrinolysis, 2001,12 (7) :547-550.
  • 10Blanche P, Si-Larbi A G, Jouve P. Femoral head necrosis and hyperhomoeysteinemia [ J ]. J Rheumatol, 2001,28 (6) : 1469.

同被引文献105

  • 1王洪欣,刘丰韬,刘震,许继平.用Logistic二元回归自变量法分析高同型半胱氨酸血症的相关因素[J].临床医学工程,2010,17(6):13-14. 被引量:3
  • 2唐毓金.他汀类药对酒精性股骨头缺血性坏死的干预作用研究进展[J].右江医学,2005,33(3):308-309. 被引量:1
  • 3David R,Thorsten M,Seyler M,et al.Treatment of early stage osteonecrosis of the femoral head[J].J Bone Joint Surg Am,2008,(90 Suppl 4):175-187.
  • 4Findlay D M,Welldon K,Atkins G J.The proliferation and phenotypic expression of human osteoblasts on tantalum metal[J].Biomaterials,2004,25 (12):2215-2227.
  • 5Itala A,Heijink A,Leerapun T,et al.Successful Canine Patellar Tendon Reattachment to Porous Tantalum[J] ,Clin Orthop,2007,463:202-207.
  • 6Mrosek E H,Schagemann J C,Chung H W,et al,Porous tantalum and poly-ε-caprolactone biocomposites for osteochondral defect repair:Preliminary studies in rabbits[J].J Orthopaedic Res,2010,28(2),141-148.
  • 7Veillette C J,Mehdian H,Schemitsch E H,et al.Survivorship analysis and radiographic outcome following tantalum rod insertion for osteonecrosis of the femoral head[J].J Bone Joint Surg Am,2006,88(Suppl 3):48-55.
  • 8Tsao A K,Roberson J R,Christie M J,et al.Biomechanical and clinical evaluations of a porous tantalum implant for the treatment of early stage osteonecrosis[J].J Bone Joint Surg Am,2005,87(Suppl 2):22-27.
  • 9Syggelos S,Megas P,Kasimatis G,et al.Tantalum rods in treament of patients in early stages of avascular necrosis of the femoral head:preliminary results[J].J Bone Joint Surg Br Proceedings,2009,91-B:135.
  • 10Liu G,Wang J,Yang S,et al.Effect of a porous tantalum rod on early and intermediate stages of necrosis of the femoral head[J].Biomed.Mater,2010,5(6):065003.

引证文献7

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部